These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1052 related items for PubMed ID: 24565519

  • 21. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
    Han L, Huang R, Liu S, Huang S, Jiang C.
    Mol Pharm; 2010 Dec 06; 7(6):2156-65. PubMed ID: 20857964
    [Abstract] [Full Text] [Related]

  • 22. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors.
    Willerding L, Limmer S, Hossann M, Zengerle A, Wachholz K, Ten Hagen TL, Koning GA, Sroka R, Lindner LH, Peller M.
    J Control Release; 2016 Jan 28; 222():47-55. PubMed ID: 26658073
    [Abstract] [Full Text] [Related]

  • 23. Tumor-penetrating Peptide-integrated Thermally Sensitive Liposomal Doxorubicin Enhances Efficacy of Radiofrequency Ablation in Liver Tumors.
    Yan F, Wang S, Yang W, Goldberg SN, Wu H, Duan WL, Deng ZT, Han HB, Zheng HR.
    Radiology; 2017 Nov 28; 285(2):462-471. PubMed ID: 28631963
    [Abstract] [Full Text] [Related]

  • 24. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors.
    Peller M, Willerding L, Limmer S, Hossann M, Dietrich O, Ingrisch M, Sroka R, Lindner LH.
    J Control Release; 2016 Sep 10; 237():138-46. PubMed ID: 27364227
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system.
    Zhang Q, Tang J, Fu L, Ran R, Liu Y, Yuan M, He Q.
    Biomaterials; 2013 Oct 10; 34(32):7980-93. PubMed ID: 23891517
    [Abstract] [Full Text] [Related]

  • 27. The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo.
    Wang C, Wang X, Zhong T, Zhao Y, Zhang WQ, Ren W, Huang D, Zhang S, Guo Y, Yao X, Tang YQ, Zhang X, Zhang Q.
    Int J Nanomedicine; 2015 Oct 10; 10():2229-48. PubMed ID: 25834435
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. In vivo study of doxorubicin-loaded cell-penetrating peptide-modified pH-sensitive liposomes: biocompatibility, bio-distribution, and pharmacodynamics in BALB/c nude mice bearing human breast tumors.
    Ding Y, Cui W, Sun D, Wang GL, Hei Y, Meng S, Chen JH, Xie Y, Wang ZQ.
    Drug Des Devel Ther; 2017 Oct 10; 11():3105-3117. PubMed ID: 29123382
    [Abstract] [Full Text] [Related]

  • 30. Thermo-Sensitive Liposome co-Loaded of Vincristine and Doxorubicin Based on Their Similar Physicochemical Properties had Synergism on Tumor Treatment.
    Li M, Li Z, Yang Y, Wang Z, Yang Z, Li B, Xie X, Song J, Zhang H, Li Y, Gao G, Yang J, Mei X, Gong W.
    Pharm Res; 2016 Aug 10; 33(8):1881-98. PubMed ID: 27075873
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
    Wu XL, Kim JH, Koo H, Bae SM, Shin H, Kim MS, Lee BH, Park RW, Kim IS, Choi K, Kwon IC, Kim K, Lee DS.
    Bioconjug Chem; 2010 Feb 17; 21(2):208-13. PubMed ID: 20073455
    [Abstract] [Full Text] [Related]

  • 37. Comparing the therapeutic potential of thermosensitive liposomes and hyperthermia in two distinct subtypes of breast cancer.
    Lokerse WJM, Bolkestein M, Dalm SU, Eggermont AMM, de Jong M, Grüll H, Koning GA.
    J Control Release; 2017 Jul 28; 258():34-42. PubMed ID: 28479096
    [Abstract] [Full Text] [Related]

  • 38. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S, Li M, Tang Z, Song W, Sun H, Liu H, Chen X.
    Acta Biomater; 2013 Dec 28; 9(12):9330-42. PubMed ID: 23958784
    [Abstract] [Full Text] [Related]

  • 39. A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma.
    Dai W, Fan Y, Zhang H, Wang X, Zhang Q, Wang X.
    Drug Deliv; 2015 Jan 28; 22(1):10-20. PubMed ID: 24735248
    [Abstract] [Full Text] [Related]

  • 40. Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage.
    Shi NQ, Gao W, Xiang B, Qi XR.
    Int J Nanomedicine; 2012 Jan 28; 7():1613-21. PubMed ID: 22619516
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 53.